Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Chronic kidney disease
•
Nephrology
•
Endocrinology
Do you recommend stopping a SGLT2i indefinitely if a patient with chronic kidney disease and diabetes develops euglycemic diabetic ketoacidosis?
Answer from: at Academic Institution
I would. In my opinion, the risk of ketoacidosis will outweigh the possible benefit from SGLTs.
Comments
at CommonSpirit
Absolutely, I would stop SGLT as one episode shoul...
at Atrium Health Wake Forest Baptist Medical Center
I would, depending on the individual patient with ...
12214
12216
Sign in or Register to read more
22632
Related Questions
Would you recommend switching a diabetic CKD patient on oral semaglutide to the subcutaneous form since the benefits in CKD have primarily been reported in studies using subcutaneous GLP-1 receptor agonists?
Are recurrent UTIs a contraindication to SGLT2i use?
Are you offering GLP-1 agonists to patients with CKD and diabetes mellitus?
Would you stop denosumab in a patient with chronic kidney disease if they develop asymptomatic hypocalcemia after the injection?
Do you pursue any additional testing in your patients with chronic kidney disease who are found to have "small hypodensities too small to characterize" on renal ultrasound?
For outpatients undergoing a kidney biopsy, do you routinely recommend an overnight admission for continued hemoglobin monitoring?
Do you recommend patients temporarily hold cilostazol prior to and after a kidney biopsy?
Do you restrict topical diclofenac use in your patients with chronic kidney disease?
Do you recommend parathyroid imaging testing for patients with recurrent nephrolithiasis who are incidentally found to have an elevated PTH but who do not have hypercalciuria, hypercalcemia, hypovitaminosis D, or chronic kidney disease?
How often do you screen for cerebral aneurysms in patients with autosomal dominant polycystic kidney disease who do not have a family history of intracranial aneurysms or for whom the family history is unknown?
Absolutely, I would stop SGLT as one episode shoul...
I would, depending on the individual patient with ...